The global Helicobacter pylori testing market is poised for remarkable expansion, with recent market research forecasting a value of USD 173.1 million by the end of 2022. This growth trend is expected to continue at a robust compound annual growth rate (CAGR) of 7.4% from 2022 to 2032, with the market projected to reach an estimated USD 380.3 million by the conclusion of the forecast period.
From 2016 to 2021, the market experienced significant growth, with a value CAGR of 6.2%. This upward trajectory is primarily driven by the increasing awareness of immunodiagnostics, particularly in developed countries such as the United States and Germany. The rising number of product approvals is also playing a crucial role in boosting the demand for Helicobacter pylori testing globally.
Helicobacter pylori testing is an essential tool for diagnosing infections in the upper small intestine and stomach, as well as evaluating the effectiveness of treatments. The bacterium is a major cause of conditions such as peptic ulcers, chronic gastritis, and gastric cancer. Early detection is vital, as Helicobacter pylori infections, though typically harmless, are responsible for over 90% of duodenal ulcers and up to 80% of gastric ulcers, according to the Centers for Disease Control and Prevention (CDC).
There are various methods of testing available, from non-invasive options like stool or breath samples to more invasive procedures that involve tissue samples obtained through endoscopy. With rising awareness and advancements in diagnostic technologies, the Helicobacter pylori testing market is expected to continue its robust growth trajectory, underscoring the global focus on gastrointestinal health.
As the market evolves, the need for improved diagnostics and greater awareness of Helicobacter pylori’s role in gastrointestinal health will be critical in meeting the growing demand for effective testing solutions worldwide.
This Rise is attributed to Several Key Factors:
- Increasing prevalence of peptic ulcers: H. pylori infection is a major culprit behind peptic ulcers. As peptic ulcer cases rise globally, the need for H. pylori testing to diagnose and manage the condition is bound to increase.
- Growing awareness and improved diagnostics: Public health efforts and advancements in diagnostic technologies are leading to better awareness of H. pylori infection. This, in turn, fuels the demand for testing.
- Focus on effective disease management: Early detection and treatment of H. pylori infection can prevent complications like peptic ulcers and stomach cancer. The growing emphasis on effective disease management strategies is propelling the H. pylori testing market.
Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!
Key Market Drivers:
- Rise in non-invasive testing: The availability of convenient and non-invasive tests, such as stool antigen tests and breath tests, is making H. pylori detection easier and more accessible.
- Technological advancements: Development of faster, more accurate, and cost-effective diagnostic tools is further driving market expansion.
- Focus on developing regions: The Asia Pacific region, with its growing population, increasing healthcare expenditure, and rising peptic ulcer cases, is expected to witness significant growth in H. pylori testing.
Key Companies Profiled:
- Abbott Laboratories
- ADI/American Diagnostica
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- Helena Laboratories
- Horiba
- Takara Bio
- EKF Diagnostics
- Exalenz Bioscience Ltd.
- Sekisui Diagnostics, LLC
Key Segments Covered in the Helicobacter Pylori Testing Industry Survey:
Helicobacter Pylori Testing Market by Test Type:
- Helicobacter Pylori Testing with Endoscopy
- Histology
- Rapid Urease Testing
- PCR (Polymerase Chain Reaction)
- Culture Testing
- Helicobacter Pylori Testing without Endoscopy
- Stool/Faecal Antigen Test
- Urea Breath Test
- H. Pylori Antibody Testing
Helicobacter Pylori Testing Market by End User:
- Helicobacter Pylori Testing in Hospitals
- Helicobacter Pylori Testing in Private Labs
- Helicobacter Pylori Testing in Public Health Labs
- Helicobacter Pylori Testing in Physician Offices
Helicobacter Pylori Testing Market by Region:
- North America Helicobacter Pylori Testing Market
- Latin America Helicobacter Pylori Testing Market
- Europe Helicobacter Pylori Testing Market
- Asia Pacific Helicobacter Pylori Testing Market
- Middle East & Africa Helicobacter Pylori Testing Market
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube